Advanced Antimicrobial Agents: Combatting Multi-Drug Resistant Bacterial Infections
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Bacterial Pathogens".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 779
Special Issue Editor
Interests: antimicrobial technology development; antibiotic resistance; nanotechnology; bioaerosols
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite the advances in antibiotic development, infectious diseases continue to affect hundreds of millions of people each year with serious outcomes, impacting public health adversely. Incorrect prescription of antibiotics and their overuse have led to the dangerous rise in antibiotic resistance. The most alarming aspect of this is the rise in multi-drug-resistant (MDR) infections. Due to the interconnected nature of the modern economy, the MDR pathogens are spreading rapidly across the globe, causing pandemics. Thus, there is a vital need to develop novel advanced antimicrobial agents for inactivating MDR pathogens.
Although this is an issue of vital importance to the field of public health, there is no focused effort in highlighting such research in the literature. In this Special Issue, we would like to highlight cutting edge research being carried out at the forefront of the battle against these MDR pathogens. Novel approaches such as nanotechnology, advanced pharmaceutical approaches, UV, and other such technologies are some research areas intended to be covered by this issue.
We look forward to featuring your exciting research in this field, which would be of great interest to the readers of the journal and the broad scientific community in general. Thank you.
Dr. Nachiket Vaze
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multi-drug resistance
- antimicrobial susceptibility
- nanoformulations
- UV disinfection
- antibiotic synergy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
